Multiple Sclerosis and Medical Cannabis

Recent research has shown that medical cannabis can help alleviate the symptoms of Multiple Sclerosis.

Understanding Multiple Sclerosis

Even today, medical experts are divided on the cause and manifestations of Multiple Sclerosis (MS). Because of the many shifting forms that MS can take, it is essential that a diagnosis is performed on anyone suffering from MS-type symptoms. Doctors can now use an MRI scan to peer inside a person’s body and locate lesions in the brain and spinal cord that are a clear indicator of MS.

MS causes multiple malfunctions in a person’s immune system, often triggering episodes in which MS causes the body to attack itself. This is negatively impacting a person’s cognition and motor function. MRI scans can locate the lesions where the body’s myelin sheaths that protect nerve cells have been attacked and destroyed. Lesions caused by MS further disrupt the nerve cell’s ability to communicate with the local area of the body that it normally services.

Symptoms of MS

Because the brain contains special nerve cells, deterioration and damage caused by MS can manifest itself in a variety of different ways, including:

  • Bladder and bowel control problems
  • Shaking, difficulty walking, and a loss of coordination
  • Shooting pains throughout the body
  • Chronic exhaustion
  • Insomnia
  • Spasms and chronic spasticity
  • Disrupted speech, including slurring and stuttering
  • The total loss of vision in an eye, accompanied by severe pain
  • Other vision problems including blurriness, inability to focus, and “double” vision
  • Dizziness
  • Weakness and loss of use of limbs on one side of the body

Medical Cannabis as Part of an MS Treatment Plan

Studies have shown that medical cannabis can be highly effective in reducing the symptoms of MS, even in patients who have suffered from it for years. CITIVA is proud to announce that they have developed a special line of cannabinoid medications that are tailored to treat common MS symptoms such as spasms, bladder control issues, shaking, insomnia, and overall pain. CITIVA eagerly looks forward to beginning clinical testing of these medications to better help the millions of people around the globe who suffer from MS.

Shaping the Future of Cannabinoid Medicine
In the


View Our


Meet the